Comparison of three different doses of intrathecal levobupivacaine in urological surgery
Trakya Universitesi Tip Fakultesi Dergisi, vol.26, no.3, pp.214-219, 2009 (SCI-Expanded, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 26 Issue: 3
- Publication Date: 2009
- Journal Name: Trakya Universitesi Tip Fakultesi Dergisi
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.214-219
- Keywords: Intrathecal, levobupivacaine, analgesia, anesthesia, SPINAL-ANESTHESIA, RACEMIC BUPIVACAINE, S(-)-BUPIVACAINE, VOLUNTEERS
- Akdeniz University Affiliated: Yes
Abstract
Objectives: The aim of our study was to compare the efficacy of hyperbaric and isobaric solutions of intrathecal levobupivacaine for transurethral endoscopic surgery. Patients and Methods: The study included urological patients who were scheduled for elective surgery under spinal anesthesia. The cases were randomly divided into three groups of 20 patients each. Group 1 received 13.5 mg hyperbaric levobupivacaine, group 2 received 12.5 mg isobaric levobupivacaine and group 3 received 15 mg isobaric levobupivacaine in a total volume of 3 ml intrathecally. Sensory and motor block, hemodynamic parameters, pain scores, adverse effects and analgesic requirements of the patients were recorded. Results: The time to reach T10 sensory block and the onset time to Bromage 0 were statistically different among the three groups (p<0.05). The mean time to reach T10 was significantly lower in group 1 when compared with group 2 (p<0.001). Regarding the mean onset time to Bromage 0, group 1 had a lower mean value than that of group 3 (p<0.001). The mean duration for analgesic requirement was longer in group 1 than in groups 2 and 3 (p<0.001 and p<0.05, respectively). Conclusion: We concluded that the clinical efficacy of hyperbaric levobupivacaine was superior to the isobaric forms in spinal anesthesia for transurethral endoscopic surgery. © Medical Journal of Trakya University. Published by Ekin Medical Publishing. All rights reserved.